Latest News for: takeda

Edit

Takeda Announces the Publication of its Annual Report on Form 20-F for FY2025 (Takeda Pharmaceutical Co Ltd)

Public Technologies 17 Jun 2026
The Annual Report can be accessed on Takeda's website at. https.//www.takeda.com/investors/sec-filings-and-security-reports/ ... About Takeda ... ## About Takeda Takeda is focused on creating better health for people and a brighter future for the world.
Edit

Annual Report for Fiscal Year Ending March 31, 2026 (Form 20-F) (Takeda Pharmaceutical Co Ltd)

Public Technologies 17 Jun 2026
Certain Supplemental Non-IFRS Measures as Defined and Presented by Takeda") ... •During the fiscal year ended March 31, 2025, Takeda decided to enter into discussions with Teva Pharmaceutical Industries Ltd ... Takeda Pharmaceutical Co.
Edit

Takeda Viet Nam Named No.1 Best Workplaces™ 2026, Reflecting a 245-Year Values-Driven Legacy

Vietnam News 09 Jun 2026
HO CHI MINH CITY, Vietnam, June 5, 2026 – Takeda Viet Nam has been named the No.1 Best Workplace™ in Vietnam 2026 (Small category) by global research and consulting firm Great Place To Work®.
Edit

Notice Concerning Issuance of New Shares and Disposal of Treasury Shares under the Long-Term Incentive Plan for Company Group Employees Outside of Japan (Form 6-K) (Takeda Pharmaceutical Co Ltd)

Public Technologies 09 Jun 2026
About Takeda. Takeda is focused on creating better health for people and a brighter future for the world ... For more information, visit www.takeda.com ... takeda.ir.contact@takeda.com ... Media_relations@takeda.com ... Takeda Pharmaceutical Co.
Edit

Notice Concerning Issuance of New Shares and Disposal of Treasury Shares under the Long-Term Incentive Plan for Company Group Employees Outside of Japan (Takeda Pharmaceutical Co Ltd)

Public Technologies 09 Jun 2026
About Takeda. Takeda is focused on creating better health for people and a brighter future for the world ... ## About Takeda Takeda is focused on creating better health for people and a brighter future for the world ... Takeda Pharmaceutical Co.
Edit

Takeda Updates FY2025 Financial Results Based on Impact of AMITIZA® Antitrust Verdict (Takeda Pharmaceutical Co Ltd)

Public Technologies 05 Jun 2026
) Revision Made to Reported Results for FY2025 - No Changes to Takeda's Core Financial Results for FY2025 No Changes to FY2026 Forecast and Management Guidance Takeda Will Vigorously Pursue Post-trial Motions and an Appeal ... Takeda Pharmaceutical Co.
Edit

TAKEDA PHARMACEUTICAL COMPANY LIMITED (Form 6-K) (Takeda Pharmaceutical Co Ltd)

Public Technologies 05 Jun 2026
Takeda Pharmaceutical Company Limited ... Takeda recently announced that, on May 18, 2026 (U.S ... Following the jury verdict, Takeda has been assessing its impact on the consolidated financial statements ... Takeda Pharmaceutical Co.
Edit

Revision of FY2025 Consolidated Financial Statements (Takeda Pharmaceutical Co Ltd)

Public Technologies 05 Jun 2026
). The text version of this document is not available ... Takeda Pharmaceutical Co.
Edit

PresentationPresentationDownload Presentation (qr2025 q4 p01 en 20260513) (Takeda Pharmaceutical Co Ltd)

Public Technologies 05 Jun 2026
). The text version of this document is not available ... Takeda Pharmaceutical Co.
Edit

FINANCIAL APPENDIX (Form 6-K) (Takeda Pharmaceutical Co Ltd)

Public Technologies 05 Jun 2026
Core Revenue represents revenue adjusted to exclude revenue items unrelated to the underlying trends and business performance of Takeda's core operations (primarily revenue or related adjustments associated with divestments and liquidations).
×